首页> 中文期刊> 《重庆医学》 >aVR 导联 ST 段抬高的非 ST 段抬高型心肌梗死介入治疗疗效分析

aVR 导联 ST 段抬高的非 ST 段抬高型心肌梗死介入治疗疗效分析

         

摘要

Objective To investigate the interventional treatment timing of patients with non-ST segment elevation myocar-dial infarction with ST segment elevation in lead aVR.Methods Totally 57 cases with non-ST segment elevation myocardial infarc-tion with ST segment elevation in lead aVR in our hospital from July 2010 to July 2013 were selected.They were divided into two groups,30 cases in group A and they were given emergency PCI treatment with in 12 hours of onset,27 cases in group B and they were given emergency PCI treatment within 12-24 hours of onset.Compare the therapeutic efficacy and adverse cardiovascular e-vents after discharge.Results Therapeutic efficacy of group A was better than group B after 1,6,12 month follow up and rate of adverse cardiovascular events of group A was shorter than group B.Conclusion Emergency PCI treatment within 12 hours can im-prove the prognosis of patients with non-ST segment elevation myocardial infarction with ST segment elevation in lead aVR.%目的:探讨aVR导联ST段抬高的非ST段抬高型心肌梗死(NSTEMI)的介入治疗时机。方法选取该院2010年7月至2013年7月收治的57例 aVR 导联 ST 段抬高的 NSTEMI 患者,将患者分为 A、B 两组,其中 A 组30例,于发病12 h 之内行急诊经皮冠状动脉介入治疗(PCI);B 组27例,于发病12~24 h 行 PCI。比较两组患者治疗效果以及出院后的不良心血管事件。结果A 组患者出院后随访1、6、12个月的治疗效果优于 B 组,不良心血管事件发生率少于 B 组。结论对于 aVR 导联 ST段抬高的 NSTEMI,在发病12 h 之内行急诊 PCI 可能更有利于患者预后的改善。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号